Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (658) Detrol LA (tolterodine tartrate), Pharmacia & Upjohn,
...Newly Approved Drug Therapies (658) Detrol LA (tolterodine tartrate), Pharmacia & Upjohn, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Detrol LA (tolterodine tartrate) Company: Pharmacia & Upjohn Approval Status: Approved December 2000 Treatment Area: Overactive Bladder General Information ...
View Page

2.  Study Posting (799) Trial #163060, Menopause, Boston, MA
...799) Trial #163060, Menopause, Boston, MA Trial Information A Cross-Over, Double Blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia (frequent night time trips to the bathroom) in Perimenopausal and ...
...Post Menopausal Women The purpose of the research study is to evaluate the effects of tolterodine on nocturia and associated sleep disturbance. Tolterodine is FDA approved for overactive bladder. Nocturia is ...
View Page

3.  Study Posting (799) Trial #152255, Menopause, Boston, MA
...799) Trial #152255, Menopause, Boston, MA Trial Information A Cross-Over, Double Blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia (frequent night time trips to the bathroom) in Perimenopausal and ...
...Post Menopausal Women The purpose of the research study is to evaluate the effects of tolterodine on nocturia and associated sleep disturbance. Tolterodine is FDA approved for overactive bladder. Nocturia is ...
View Page

4.  Newly Approved Drug Therapies (426) Detrol (tolterodine tartrate), Pharmacia & Upjohn,
...Newly Approved Drug Therapies (426) Detrol (tolterodine tartrate), Pharmacia & Upjohn, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Detrol (tolterodine tartrate) Company: Pharmacia & Upjohn Approval Status: Approved March 1998 Treatment Area: overactive bladder General Information ...
View Page

5.  Study Posting (3562) Trial #137425, Bladder Disorders, Tacoma, WA
...Trial Information A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
...parallel group study comparing three doses of SSR240600 (25, 50 and 100mg) to placebo using tolterodine (Detrol LA) as a calibrator. The study consists of 3 phases: • A screening period of ...
View Page

6.  Study Posting (3562) Trial #137474, Bladder Disorders, Tacoma, WA
...Trial Information A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
...parallel group study comparing three doses of SSR240600 (25, 50 and 100mg) to placebo using tolterodine (Detrol LA) as a calibrator. The study consists of 3 phases: • A screening period of ...
View Page

7.  Study Posting (1768) Trial #85414, Urinary Incontinence, Staten Island, NY
...Official Title: A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolerodine ER, Tamsulosin, and Tolterodine ER Plus (Tamsulosin) Study to Evaluate the Clinical Efficacy and Safety of Tolterodine ER 4mg in Men Who Have Frequency and Urgency, With or Without Urinary Urge Incontinence ...
View Page

8.  Study Posting (1768) Trial #85415, Bladder Disorders, Staten Island, NY
...Official Title: A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolerodine ER, Tamsulosin, and Tolterodine ER Plus (Tamsulosin) Study to Evaluate the Clinical Efficacy and Safety of Tolterodine ER 4mg in Men Who Have Frequency and Urgency, With or Without Urinary Urge Incontinence ...
View Page

9.  Study Posting (4036) Trial #94714, Bladder Disorders, Hollywood, FL
...24 hours • with or without UUIE • Patient’s dissatisfaction with previous oxybutynin extended release or tolterodine extended release treatment whichever was the most recent treatment for OAB prior to this study ...
View Page

10.  CenterWatch: Clinical Trials in Category (181) Menopause
...Postmenopausal Women Massachusetts Boston : Massachusetts General Hospital New! A Cross-Over, Double Blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia (frequent night time trips to the bathroom) in Perimenopausal and ...
View Page

11.  Study Posting (4960) Trial #130285, Bladder Disorders, New London, CT
...the safety and efficacy of the investigational drug fesoterodine in comparison to an approved drug tolterodine and placebo (dummy drug) for overactive bladder. In order to achieve this evaluation in an ...
View Page

12.  CenterWatch Clinical Research Profile (3562) Trial #1576, Tacoma Women's Specialists Clinical Research Center, Tacoma, WA
...overactive bladder. • A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
...II study • A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
View Page

13.  CenterWatch: Nephrology/Urology Approved Drug Therapies
...Cefazolin and Dextrose USP ; B Braun Medical; Respiratory tract infections, Approved July 2000 Detrol LA (tolterodine tartrate) ; Pharmacia & Upjohn; For the treatment of overactive bladder with symptoms of urge urinary incontinence ...
...Tequin ; Bristol-Myers Squibb; Tequin (Injectable and Tablet), December, 1999 Drugs Approved in 1998 Detrol (tolterodine tartrate) ; Pharmacia & Upjohn; Treatment for an overactive bladder, Approved March 1998 Ditropan XL (oxybutynin chloride ...
View Page

14.  CenterWatch Clinical Research Profile (799) Trial #350, Massachusetts General Hospital, Boston, MA
...by FDG-PET in High Risk Atherosclerotic Patients • A Cross-Over, Double Blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia (frequent night time trips to the bathroom) in Perimenopausal and ...
View Page

15.  Newly Approved Drug Therapies (822) Oxytrol (oxybutynin transdermal system), Watson Pharmaceuticals,
...upset. NCMJ 2001 Mar/April;62(2):74-77. Harvey MA, Baker K, Wells GA. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am J Obstet ...
View Page

16.  Newly Approved Drug Therapies (1003) Toviaz (fesoterodine fumarate), Pfizer,
...Chapple CR, Van Kerrebroeck PE, Jünemann KP, Wang JT, Brodsky M Comparison of fesoterodine and tolterodine in patients with overactive bladder. BJU International 2008 Jul 21 Kelleher CJ, Tubaro A, Wang ...
View Page

17.  CenterWatch: Clinical Trials in Category (445) Bladder Disorders
...Research Center A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
...Research Center A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive ...
View Page

18.  CenterWatch: List of Newly Approved Drug Thearapies
...for prevention of blood clots following hip-replacement surgery, Approved February 1998 Nephrology/Urology Detrol (tolterodine tartrate) ; Pharmacia & Upjohn; Treatment for an overactive bladder, Approved March 1998 Ditropan XL (oxybutynin chloride ...
View Page

19.  CenterWatch: List of Newly Approved Drug Thearapies
...Cefazolin and Dextrose USP ; B Braun Medical; Respiratory tract infections, Approved July 2000 Detrol LA (tolterodine tartrate) ; Pharmacia & Upjohn; For the treatment of overactive bladder with symptoms of urge urinary incontinence ...
View Page